| Chemotherapy Utilization and Outcome for Stage IV NSCLC in Community, University and Veterans system.
A M Safar and Pat Coke. Lung Cancer. Suppl. 1 vol 34. October 2001. p S42.
Biventricular Cardiac Thrombosis during Interleukin-2 Infusion. Junghans RP, Manning W, Safar M, Quist W. New England Journal of Medicine. 344 (11): 859.
IL2 maintains biologic activity and sterility over prolonged time.
A.M.Safar and R.P.Junghans. Immunopharmacology. 49 (2000) 419-423.
Steroid premedication before IV contrast-enhanced CT resulting in resolution of lymphadenopathy. AJR, Jan. 1998, p218-9. T Wong, JD Levine,
AM Safar, EL Jones
Preclinical and Phase I data of anti-CEA dsigner T-cell therapy for cancer: A new immunotherapeutic modality. R.P. Junghans,
M. Safar, M.S. Huberman, Q. Ma, R. Ripley, S.O. Leung, and E.J. Beecham. Proc. AACR, # 3461. Vol. 41. 2000.
Phase I trial of Gemcitabine, Cisplatin (CDDP) and external beam radiation therapy (EBRT) for locally advanced pancreatic cancer.
A. Mazin Safar, Pedro Sanz Altamira, Mary Anne Stevensen, Abram Recht, Keith Stuart. Proc. ASCO 1999 Abs 874.
|
